Manhattan Associates Inc vs Personalis Inc. Common Stock — how do they compare? Manhattan Associates Inc trades at $216.88 (market cap $12.99B), while Personalis Inc. Common Stock trades at $16.07 (market cap $1.69B). The key difference: Manhattan Associates Inc is far larger — about 7.7× Personalis Inc. Common Stock's market cap, and Manhattan Associates Inc is trading nearer its 52-week high, Personalis Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Manhattan Associates Inc for 11 Days and Personalis Inc. Common Stock for 0 Days on average.
| MANH | PSNL | |
|---|---|---|
Market Cap | $12.99B | $1.69B |
Volume | 546,880 | 3,817,236 |
Sector | Technology | Health |
52-Week High | $223.76 | $18.38 |
52-Week Low | $120.88 | $5.04 |
Typical Hold Time | 11 Days | 0 Days |
Enterprise Value | $12.85B | $1.52B |
Signals from Pluang's Aura AI — not financial advice
MANH trades at $222.71, up 2.21% today, with a bullish technical signal and strong profitability metrics including a 96.38% ROE. Recent earnings have consistently beaten expectations, and the company launched new Editions solutions to expand market access. However, high valuation ratios and a legal investigation pose headwinds.
The outlook remains positive with 80% analyst buy ratings and a $219.25 consensus target, but risks include elevated P/E of 63.81 and potential fiduciary breach concerns. Earnings growth and product innovation are key catalysts, yet investors should weigh valuation against legal and competitive pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →